Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal change in lung function in a single-centre cohort

Heba M. Bintalib, David M. Lowe, Gaia Mancuso, Georgia Gkrepi, Suranjith L. Seneviratne, Siobhan O. Burns, John R. Hurst

Source: ERJ Open Res, 8 (4) 00024-2022; 10.1183/23120541.00024-2022
Journal Issue: October

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides
For technical reasons, this interactive material needs to open in a new window.
Please allow pop-ups from ers-education.org.
If the window did not open automatically, please click here.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Heba M. Bintalib, David M. Lowe, Gaia Mancuso, Georgia Gkrepi, Suranjith L. Seneviratne, Siobhan O. Burns, John R. Hurst. Corticosteroid-induced remission and mycophenolate maintenance therapy in granulomatous lymphocytic interstitial lung disease: long-term, longitudinal change in lung function in a single-centre cohort. ERJ Open Res, 8 (4) 00024-2022; 10.1183/23120541.00024-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.